Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans

Mucosal Immunology
M MöndelJ Wehkamp

Abstract

Inducible epithelial human beta-defensins (hBD) play an important role in intestinal barrier function. In vitro studies showed that clinically effective probiotics induce antimicrobial hBD-2. Here, we aimed to assess the in vivo effect in healthy volunteers and also addressed how defensins affect probiotic survival. Symbioflor 2 containing one strain of several viable genotypes of Escherichia coli was administered to 23 healthy individuals. After 3 weeks, fecal hBD-2 peptide was increased in 78% (mean 3.7-fold; P<0.0001). Interestingly, the fecal hBD-2 peptide was still elevated 9 weeks after treatment (P=0.008). In vitro studies revealed that this effect was mediated by only one out of three tested E. coli genotypes and comparable to probiotic E. coli Nissle 1917 (10- to 15-fold). Functional assays showed that all tested bacteria were similarly killed by defensins allowing to speculate about a suicidal character of this effect. Defensin induction seems to be a common and important mechanism of probiotic treatment.

References

Mar 21, 1991·Journal of Immunological Methods·R I LehrerP Eisenhauer
Jun 15, 1999·Pediatric Research·K M Huttner, C L Bevins
Feb 7, 2001·The American Journal of Clinical Nutrition·P R MarteauJ Schrezenmeir
Feb 24, 2001·Cellular and Molecular Life Sciences : CMLS·J M Schröder
Jun 8, 2001·The American Journal of Clinical Nutrition·J M Saavedra
Aug 9, 2002·The New England Journal of Medicine·Daniel K Podolsky
Nov 1, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·P GionchettiM Campieri
Dec 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jan WehkampCharles L Bevins
Oct 13, 2006·Current Opinion in Gastroenterology·R B Sartor
Feb 9, 2007·European Journal of Pediatrics·Jobst HenkerJürgen Schulze
Jun 5, 2007·Current Opinion in Gastroenterology·Jan WehkampEduard F Stange
Jan 15, 2008·Clinical and Experimental Immunology·M SchleeK Fellermann

❮ Previous
Next ❯

Citations

Sep 17, 2013·EMBO Molecular Medicine·Maureen J OstaffJan Wehkamp
Nov 20, 2012·Langenbeck's Archives of Surgery·Simon JägerJan Wehkamp
Sep 27, 2013·World Journal of Microbiology & Biotechnology·Esther Swee Lan Chong
May 15, 2013·International Journal of Antimicrobial Agents·Maria TheodorakopoulouGeorge Dimopoulos
Jun 15, 2010·The Proceedings of the Nutrition Society·Jean Michel Antoine
Mar 27, 2012·Animal : an International Journal of Animal Bioscience·M KennyB Miller
Jul 3, 2013·Antimicrobial Agents and Chemotherapy·Andreia Bergamo EstrelaWolf-Rainer Abraham
Oct 19, 2010·Applied and Environmental Microbiology·D O KrauseC M Nyachoti
Mar 16, 2011·BMC Medicine·Stephan C Bischoff
Dec 15, 2010·International Journal of Inflammation·Simon JägerJan Wehkamp
Apr 2, 2014·Critical Care : the Official Journal of the Critical Care Forum·Shanmiao GouChunyou Wang
Jul 22, 2010·Nutrition Reviews·Ilja TrebichavskyAlla Splichalova
Jul 7, 2011·Nutrition Reviews·Taylor C WallaceMary Ellen Sanders
Dec 3, 2010·Journal of Crohn's & Colitis·Jan Wehkamp, Eduard F Stange
Aug 6, 2009·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·T Volz, T Biedermann
Apr 8, 2009·Current Opinion in Gastroenterology·Hao Wu, Bo Shen
Aug 7, 2009·Expert Opinion on Emerging Drugs·Luca PastorelliMaurizio Vecchi
Sep 24, 2015·Journal of Food Science and Technology·Bathal Vijaya KumarObulam Vijaya Sarathi Reddy
Dec 29, 2012·Beneficial Microbes·K Tsilingiri, M Rescigno
Apr 19, 2016·Nutrition Research Reviews·Warren M Miner-Williams, Paul J Moughan
Jun 20, 2015·Journal of Immunology Research·GianMarco GiorgettiAntonio Tursi
Jun 21, 2012·Gut Microbes·Katerina Tsilingiri, Maria Rescigno
Jan 30, 2015·Critical Reviews in Food Science and Nutrition·L Y M WanH El-Nezami
Jan 9, 2015·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Dirk Haller, G Hörmannsperger
Apr 4, 2013·Molecular Pharmaceutics·Gaëlle VacherGerrit Borchard
Oct 24, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jane M M Natividad, Elena F Verdu
Jan 18, 2013·Digestive Diseases·Luc Biedermann, Gerhard Rogler
Nov 20, 2012·Innate Immunity·Ernesto Prado Montes de Oca
Sep 18, 2013·JPEN. Journal of Parenteral and Enteral Nutrition·Joseph F PierreKenneth A Kudsk
Apr 5, 2012·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Lee E MorrowMark A Malesker
Oct 31, 2014·Inflammatory Bowel Diseases·Gerhard Rogler, Stephan Vavricka
Sep 1, 2017·Journal of Medical Microbiology·Feride KaracaerDilek Özcengiz
Nov 16, 2017·Nature Communications·Smarajit ChakrabortyLinda J Kenney
Jul 29, 2010·Nature Reviews. Gastroenterology & Hepatology·Mélanie G GareauW Allan Walker
Oct 29, 2014·Intestinal research·Jung Mogg Kim
Aug 8, 2009·The American Journal of Gastroenterology·Andreas SchwiertzKerstin Rusch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.